Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment von Shin, J. H., Gadde, K. M., Østbye, T., Bray, G. A.

Volltext

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial von Gadde, K.M, Yonish, G.M, Wagner, H.R. II, Foust, M.S, Allison, D.B

Volltext

Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity von Bays, H E, Gadde, K M

Volltext

Panic disorder: Growth hormone and IGF responses to exercise von Gadde, K.M., Uhde, T.W.

Volltext

34. Serotonin transporter genotypes, CSF 5HIAA, and cardiovascular reactivity to stress von Williams, R.B., Barefoot, J.C., Clary, G., Gadde, K.M., Grichnik, K., Helms, M.J., Kuhn, C.M., Marchuk, D.A., Schanberg, S.M., Siegler, I.C., Stafford-Smith, M., Suarez, E.C., Svenson, I.K.

Volltext

1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma... von Galsky, M.D., Koshkin, V.S., Campbell, M.T., Drakaki, A., Bowman, I., Rose, A.A.N., Brown, J.R., Aragon-Ching, J.B., Gadde, S., Harandi, A., Rosenberg, J.E., Matsubara, N., Sokolowski, K.M., Ichimaru, M., Chan, S., Franco, S., Powles, T.B.

Volltext